Clinical Trial ID: NCT05812807
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Zuberi, Lara
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05812807
Secondary Trial ID Number
A012103 / OptimICE; NCI-2022-07859
Keywords
Treatment